A recent study showed that for lung adenocarcinoma (LUAD), GGT5 was specifically highly expressed in cancer-associated fibroblasts instead of the tumor cells, which was proven to contribute to accelerating tumor cell proliferation and drug resistance in LUAD. The gene discussed is GGT5; the disease is cancer.